"The US Food and Drug Administration (FDA) has approved Akorn Inc's phenylephrine hydrochloride ophthalmic solution (2.5% and 10%), the company has announced.
The alpha-1 adrenergic receptor agonist is commonly used by optometrists, ophtha"...
Zymaxid Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Zymaxid (gatifloxacin) Ophthalmic Solution 0.5% is a fluoroquinolone antibiotic used to treat bacterial conjunctivitis. Common side effects of Zymaxid include eye irritation or pain, worsening of conjunctivitis, and changes in taste.
The dose of Zymaxid is one drop instilled every two hours in the affected eye(s) while awake, up to 8 times on Day 1. Instill one drop two to four times daily in the affected eye(s) while awake on Days 2 through 7. Zymaxid may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Zymaxid should be used only if prescribed. It is unknown if Zymaxid passes into breast milk. Consult your doctor before breastfeeding.
Our Zymaxid (gatifloxacin) Ophthalmic Solution 0.5% Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Zymaxid FDA Prescribing Information: Side Effects
Clinical Studies Experience
Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.
In clinical studies with ZYMAXID® , the most frequently reported adverse reactions occurring in ≥ 1% of patients in the gatifloxacin study population (N=717) were: worsening of the conjunctivitis, eye irritation, dysgeusia, and eye pain.
Additional adverse events reported with other formulations of gatifloxacin ophthalmic solution include chemosis, conjunctival hemorrhage, dry eye, eye discharge, eyelid edema, headache, increased lacrimation, keratitis, papillary conjunctivitis, and reduced visual acuity.
Read the entire FDA prescribing information for Zymaxid (Gatifloxacin Ophthalmic Solution)
Additional Zymaxid Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.